Role of the peroxisome proliferator-activated receptors (PPAR)-α, β/δ and γ triad in regulation of reactive oxygen species signaling in brain

Biological Chemistry

Volumn 394, Issue 12, 2013, Pages 1553-1570

  Aleshin, Stepan ^a   Reiser, Georg ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Catalase; Glutathione; Inflammation; Neuroprotection; Superoxide dismutase

Indexed keywords

2 CHLORO 5 NITRO N (4 PYRIDYL)BENZAMIDE; 2 CHLORO 5 NITROBENZANILIDE; 3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; [2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; BEZAFIBRATE; CATALASE; CIPROFIBRATE; CYTOCHROME C OXIDASE; FENOFIBRATE; GEMFIBROZIL; GW 501615; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXYNITRITE; PIOGLITAZONE; PIRINIXIC ACID; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ROSIGLITAZONE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; WY 14463;

ANTIOXIDANT ACTIVITY; BRAIN DISEASE; BRAIN TISSUE; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME INDUCTION; EPILEPTIC STATE; HUMAN; NEUROPROTECTION; NEUROSCIENCE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; THERAPY EFFECT;

ANIMALS; BRAIN; HUMANS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PPAR ALPHA; PPAR DELTA; PPAR GAMMA; PPAR-BETA; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84888083879     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2013-0215     Document Type: Review

References (117)

1. Aleshin, S., Grabeklis, S., Hanck, T., Sergeeva, M., and Reiser, G. (2009). Peroxisome proliferator-activated receptor (PPAR)-γ positively controls and PPARα negatively controls cyclooxygenase- 2 expression in rat brain astrocytes through a convergence on PPARβ/δ via mutual control of PPAR expression levels. Mol. Pharmacol. 76, 414-424.
2. Aleshin, S., Strokin, M., Sergeeva, M., and Reiser, G. (2013). Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ- dependent molecular pathways in neurodegenerative diseases; review and novel hypotheses. Neurochem. Int. 63, 322-330.
3. Ansari, M.A. and Scheff, S.W. (2011). NADPH-oxidase activation and cognition in Alzheimer disease progression. Free Radic. Biol. Med. 51, 171-178.
4. Antonenkov, V.D., Grunau, S., Ohlmeier, S., and Hiltunen, J.K. (2010). Peroxisomes are oxidative organelles. Antioxid. Redox Signal. 13, 525-537.
5. Armogida, M., Nistico, R., and Mercuri, N.B. (2012). Therapeutic potential of targeting hydrogen peroxide metabolism in the treatment of brain ischaemia. Br. J. Pharmacol. 166, 1211-1224.
6. Arsenijevic, D., de Bilbao, F., Plamondon, J., Paradis, E., Vallet, P., Richard, D., Langhans, W., and Giannakopoulos, P. (2006). Increased infarct size and lack of hyperphagic response after focal cerebral ischemia in peroxisome proliferator-activated receptor β-deficient mice. J. Cereb. Blood Flow Metab. 26, 433-445.
7. Aubourg, P. and Wanders, R. (2013). Peroxisomal disorders. Handb. Clin. Neurol. 113, 1593-1609.
8. Bastin, J., Aubey, F., Rotig, A., Munnich, A., and Djouadi, F. (2008). Activation of peroxisome proliferator-activated receptor pathway stimulates the mitochondrial respiratory chain and can correct deficiencies in patients' cells lacking its components. J. Clin. Endocrinol. Metab. 93, 1433-1441. (Pubitemid 351519745)
9. Battistini, S., Ricci, C., Lotti, E.M., Benigni, M., Gagliardi, S., Zucco, R., Bondavalli, M., Marcello, N., Ceroni, M., and Cereda, C. (2010). Severe familial ALS with a novel exon 4 mutation (L106F) in the SOD1 gene. J. Neurol. Sci. 293, 112-115.
10. Becker, J., Delayre-Orthez, C., Frossard, N., and Pons, F. (2008). Regulation of peroxisome proliferator-activated receptor-α expression during lung inflammation. Pulm. Pharmacol. Ther. 21, 324-330. (Pubitemid 351320570)
11. Bellinger, F.P., Bellinger, M.T., Seale, L.A., Takemoto, A.S., Raman, A.V., Miki, T., Manning-Boǧ, A.B., Berry, M.J., White, L.R., and Ross, G.W. (2011). Glutathione Peroxidase 4 is associated with Neuromelanin in Substantia Nigra and Dystrophic Axons in Putamen of Parkinson's brain. Mol. Neurodegener. 6, 8.
12. Bernardo, A., Bianchi, D., Magnaghi, V., and Minghetti, L. (2009). Peroxisome proliferator-activated receptor-γ agonists promote differentiation and antioxidant defenses of oligodendrocyte progenitor cells. J. Neuropathol. Exp. Neurol. 68, 797-808.
13. Bhateja, D.K., Dhull, D.K., Gill, A., Sidhu, A., Sharma, S., Reddy, B.V., and Padi, S.S. (2012). Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid-induced behavioral and biochemical alterations in rats: possible neuroprotective mechanisms. Eur. J. Pharmacol. 674, 33-43.
14. Bordet, R., Ouk, T., Petrault, O., Gelé, P., Gautier, S., Laprais, M., Deplanque, D., Duriez, P., Staels, B., Fruchart, J.C., and Bastide, M. (2006). PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases. Biochem. Soc. Trans. 34, 1341-1346. (Pubitemid 46769051)
15. Chakravarthy, M.V., Zhu, Y., Lopez, M., Yin, L., Wozniak, D.F., Coleman, T., Hu, Z., Wolfgang, M., Vidal-Puig, A., Lane, M.D., et al. (2007). Brain fatty acid synthase activates PPARα to maintain energy homeostasis. J. Clin. Invest. 117, 2539-2552. (Pubitemid 47494355)
16. Chen, X.R., Besson, V.C., Palmier, B., Garcia, Y., Plotkine, M., and Marchand-Leroux, C. (2007). Neurological recovery-promoting, anti-inflammatory, and anti-oxidative effects afforded by fenofibrate, a PPAR alpha agonist, in traumatic brain injury. J. Neurotrauma 24, 1119-1131. (Pubitemid 47106286)
17. Choi, D.H., Cristovao, A.C., Guhathakurta, S., Lee, J., Joh, T.H., Beal, M.F., and Kim, Y.S. (2012). NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson's disease. Antioxid. Redox Signal. 16, 1033-1045.
18. Chuang, Y.C., Lin, T.K., Huang, H.Y., Chang, W.N., Liou, C.W., Chen, S.D., Chang, A.Y., and Chan, S.H. (2012). Peroxisome proliferator-activated receptors γ/mitochondrial uncoupling protein 2 signaling protects against seizure-induced neuronal cell death in the hippocampus following experimental status epilepticus. J. Neuroinflammation 9, 184.
19. Cimini, A., Benedetti, E., Cristiano, L., Sebastiani, P., D'Amico, M.A., D'Angelo, B., and Di Loreto, S. (2005). Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons. Neuroscience 130, 325-337. (Pubitemid 40125471)
20. Collino, M., Aragno, M., Mastrocola, R., Benetti, E., Gallicchio, M., Dianzani, C., Danni, O., Thiemermann, C., and Fantozzi, R. (2006a). Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: effects of the PPAR-α agonist WY14643. Free Radic. Biol. Med. 41, 579-589. (Pubitemid 44080506)
21. Collino, M., Aragno, M., Mastrocola, R., Gallicchio, M., Rosa, A.C., Dianzani, C., Danni, O., Thiemermann, C., and Fantozzi, R. (2006b). Modulation of the oxidative stress and inflammatory response by PPAR-γ agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion. Eur. J. Pharmacol. 530, 70-80. (Pubitemid 43037126)
22. Crosby, M.B., Svenson, J., Gilkeson, G.S., and Nowling, T.K. (2005). A novel PPAR response element in the murine iNOS promoter. Mol. Immunol. 42, 1303-1310. (Pubitemid 40798946)
23. Cullingford, T.E., Dolphin, C.T., and Sato, H. (2002). The peroxisome proliferator-activated receptor α-selective activator ciprofibrate upregulates expression of genes encoding fatty acid oxidation and ketogenesis enzymes in rat brain. Neuropharmacol. 42, 724-730. (Pubitemid 34457754)
24. Daff, S. (2010). NO synthase: structures and mechanisms. Nitric Oxide 23, 1-11.
25. Damier, P., Hirsch, E.C., Zhang, P., Agid, Y., and Javoy-Agid, F. (1993). Glutathione peroxidase, glial cells and Parkinson's disease. Neuroscience 52, 1-6. (Pubitemid 23026600)
26. Defaux, A., Zurich, M.G., Braissant, O., Honegger, P., and Monnet-Tschudi, F. (2009). Effects of the PPAR-β agonist GW501516 in an in vitro model of brain inflammation and antibody-induced demyelination. J. Neuroinflammation 6, 15.
27. Fan, Y., Wang, Y., Tang, Z., Zhang, H., Qin, X., Zhu, Y., Guan, Y., Wang, X., Staels, B., Chien, S., et al., (2008). Suppression of pro-inflammatory adhesion molecules by PPAR-δ in human vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 28, 315-321. (Pubitemid 351161205)
28. Fransen, M., Nordgren, M., Wang, B., and Apanasets, O. (2012). Role of peroxisomes in ROS/RNS-metabolism: implications for human disease. Biochim. Biophys. Acta 1822, 1363-1373.
29. Garcia-Bueno, B., Madrigal, J.L., Lizasoain, I., Moro, M.A., Lorenzo, P., and Leza, J.C. (2005). Peroxisome proliferator-activated receptor gamma activation decreases neuroinflammation in brain after stress in rats. Biol. Psychiatry 57, 885-894. (Pubitemid 40488357)
30. Girnun, G.D., Domann, F.E., Moore, S.A., and Robbins, M.E. (2002). Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter. Mol. Endocrinol. 16, 2793-2801. (Pubitemid 36020658)
31. Glatz, T., Stock, I., Nguyen-Ngoc, M., Gohlke, P., Herdegen, T., Culman, J., and Zhao, Y. (2010). Peroxisome-proliferatoractivated receptors γ and peroxisome-proliferator-activated receptors β/δ and the regulation of interleukin 1 receptor antagonist expression by pioglitazone in ischaemic brain. J. Hypertens. 28, 1488-1497.
32. Gray, E., Ginty, M., Kemp, K., Scolding, N., and Wilkins, A. (2011). Peroxisome proliferator-activated receptor-α agonists protect cortical neurons from inflammatory mediators and improve peroxisomal function. Eur. J. Neurosci. 33, 1421-1432.
33. Gray, E., Ginty, M., Kemp, K., Scolding, N., and Wilkins, A. (2012). The PPAR-γ agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function. J. Neuroinflammation 9, 63.
34. Heneka, M.T. and Landreth, G.E. (2007). PPARs in brain. Biochim. Biophys. Acta. 1771, 1031-1045.
35. Inoue, I., Noji, S., Awata, T., Takahashi, K., Nakajima, T., Sonoda, M., Komoda, T., and Katayama, S. (1998). Bezafibrate has an antioxidant effect: peroxisome proliferator-activated receptor α is associated with Cu2+, Zn2+-superoxide dismutase in the liver. Life Sci. 63, 135-144. (Pubitemid 28298667)
36. Jin, Y.N., Hwang, W.Y., Jo, C., and Johnson, G.V. (2012). Metabolic state determines sensitivity to cellular stress in Huntington disease: normalization by activation of PPARγ. PLoS One 7, e30406.
37. Jung, T.W., Lee, J.Y., Shim, W.S., Kang, E.S., Kim, S.K., Ahn, C.W., Lee, H.C., and Cha, B.S. (2007). Rosiglitazone protects human neuroblastoma SH-SY5Y cells against MPP+ induced cytotoxicity via inhibition of mitochondrial dysfunction and ROS production. J. Neurol. Sci. 253, 53-60. (Pubitemid 46185454)
38. Kalonia, H., Kumar, P., and Kumar, A. (2010). Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid-induced neurotoxicity: possible role of peroxisome proliferator activated receptor-γ (PPARγ) in Huntington's disease. Pharmacol. Biochem. Behav. 96, 115-124.
39. Kang, J., Yang, M., Jou, I., and Joe, E. (2001). Identification of protein kinase C isoforms involved in interferon-gamma-induced expression of inducible nitric oxide synthase in murine BV2 microglia. Neurosci. Lett. 299, 205-208. (Pubitemid 32124847)
40. Kaur, B., Singh, N., and Jaggi, A.S. (2009). Exploring mechanism of pioglitazone-induced memory restorative effect in experimental dementia. Fundam. Clin. Pharmacol. 23, 557-566.
41. Kersten, S., Mandard, S., Escher, P., Gonzalez, F.J., Tafuri, S., Desvergne, B., and Wahli, W. (2001). The peroxisome proliferator-activated receptor α regulates amino acid metabolism. FASEB J. 15, 1971-1978. (Pubitemid 32848801)
42. Kim, D.J., Murray, I.A., Burns, A.M., Gonzalez, F.J., Perdew, G.H., and Peters, J.M. (2005). Peroxisome proliferator-activated receptor- β/δ inhibits epidermal cell proliferation by down-regulation of kinase activity. J. Biol. Chem. 280, 9519-9527. (Pubitemid 40409647)
43. Kim, H.J., Ham, S.A., Paek, K.S., Hwang JS, Jung SY, Kim MY, Jin H, Kang ES, Woo IS, Kim HJ, et al., (2011). Transcriptional up-regulation of antioxidant genes by PPARδ inhibits angiotensin II-induced premature senescence in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 406, 564-569.
44. Kim, Y.C., Park, T.Y., Baik, E., and Lee, S.H. (2012). Fructose-1,6-bisphosphate attenuates induction of nitric oxide synthase in microglia stimulated with lipopolysaccharide. Life Sci. 90, 365-372.
45. Kinouchi, H., Epstein, C.J., Mizui, T., Carlson, E., Chen, S.F., and Chan, P.H. (1991). Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. Proc. Natl. Acad. Sci. USA 88, 11158-11162. (Pubitemid 21915999)
46. Knott, A.B. and Bossy-Wetzel, E. (2009). Nitric oxide in health and disease of the nervous system. Antioxid. Redox Signal. 11, 541-554.
47. Krey, G., Braissant, O., L'Horset, F., Kalkhoven, E., Perroud, M., Parker, M.G., and Wahli, W. (1997). Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11, 779-791. (Pubitemid 27225305)
48. Lambeth, J.D. (2004). NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4, 181-189. (Pubitemid 38339084)
49. Lee, T.I., Kao, Y.H., Chen, Y.C., and Chen, Y.J. (2009). Proinflammatory cytokine and ligands modulate cardiac peroxisome proliferator-activated receptors. Eur. J. Clin. Invest. 39, 23-30.
50. Leisewitz, A.V., Urrutia, C.R., Martinez, G.R., Loyola, G., and Bronfman, M. (2008). A PPARs cross-talk concertedly commits C6 glioma cells to oligodendrocytes and induces enzymes involved in myelin synthesis. J. Cell Physiol. 217, 367-376.
51. Lemay, D.G. and Hwang, D.H. (2006). Genome-wide identification of peroxisome proliferator response elements using integrated computational genomics. J. Lipid Res. 47, 1583-1587. (Pubitemid 44079913)
52. Li, X., Du, J., Xu, S., Lin, X., and Ling, Z. (2013). Peroxisome proliferator-activated receptor-γ agonist rosiglitazone reduces secondary damage in experimental spinal cord injury. J. Int. Med. Res. 41, 153-161.
53. Lin, M.T. and Beal, M.F. (2006). Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787-795. (Pubitemid 44622683)
54. Linscheid, P., Keller, U., Blau, N., Schaer, D.J., and Muller, B. (2003). Diminished production of nitric oxide synthase cofactor tetrahydrobiopterin by rosiglitazone in adipocytes. Biochem. Pharmacol. 65, 593-598. (Pubitemid 36144244)
55. Liu, N., Qiang, W., Kuang, X., Thuillier, P., Lynn, W.S., and Wong, P.K. (2002). The peroxisome proliferator phenylbutyric acid (PBA) protects astrocytes from ts1 MoMuLV-induced oxidative cell death. J. Neurovirol. 8, 318-325. (Pubitemid 34982337)
56. Liu, X., Luo, D., Zheng, M., Hao, Y., Hou, L., and Zhang, S. (2010). Effect of pioglitazone on insulin resistance in fructose-drinking rats correlates with AGEs/RAGE inhibition and block of NADPH oxidase and NF kappa B activation. Eur. J. Pharmacol. 629, 153-158.
57. Liu, J., Wang, P., Luo, J., Huang, Y., He, L., Yang, H., Li, Q., Wu, S., Zhelyabovska, O., and Yang, Q. (2011). Peroxisome proliferatoractivated receptor β/δ activation in adult hearts facilitates mitochondrial function and cardiac performance under pressure-overload condition. Hypertension 57, 223-230.
58. Loh, K.P., Huang, S.H., De Silva, R., Tan, B.K., and Zhu, Y.Z. (2006). Oxidative stress: apoptosis in neuronal injury. Curr. Alzheimer Res. 3, 327-337. (Pubitemid 44351476)
59. Luo, Y., Yin, W., Signore, A.P., Zhang, F., Hong, Z., Wang, S., Graham, S.H., and Chen, J. (2006). Neuroprotection against focal ischemic brain injury by the peroxisome proliferatoractivated receptor-γ agonist rosiglitazone. J. Neurochem. 97, 435-448.
60. Madrigal, J.L., Garcia-Bueno, B., Caso, J.R., Perez-Nievas, B.G., and Leza, J.C. (2006). Stress-induced oxidative changes in brain. CNS Neurol. Disord. Drug Targets 5, 561-568. (Pubitemid 44523873)
61. Madrigal, J.L., Kalinin, S., Richardson, J.C., and Feinstein, D.L. (2007). Neuroprotective actions of noradrenaline: effects on glutathione synthesis and activation of peroxisome proliferator activated receptor delta. J. Neurochem. 103, 2092-2101. (Pubitemid 350126619)
62. Maier, C.M. and Chan, P.H. (2002). Role of superoxide dismutases in oxidative damage and neurodegenerative disorders. Neuroscientist 8, 323-334. (Pubitemid 34824016)
63. Marklund, S.L., Holme, E., and Hellner, L. (1982). Superoxide dismutase in extracellular fluids. Clin. Chim. Acta. 126, 41-51. (Pubitemid 13242364)
64. Mattson, M.P. (2007). Calcium and neurodegeneration. Aging Cell 6, 337-350.
65. Medhi, B., Aggarwal, R., and Chakrabarti, A. (2010). Neuroprotective effect of pioglitazone on acute phase changes induced by partial global cerebral ischemia in mice. Indian J. Exp. Biol. 48, 793-799.
66. Miglio, G., Rosa, A.C., Rattazzi, L., Collino, M., Lombardi, G., and Fantozzi, R. (2009). PPARγ stimulation promotes mitochondrial biogenesis and prevents glucose deprivation-induced neuronal cell loss. Neurochem. Int. 55, 496-504.
67. Mohagheghi, F., Khalaj, L., Ahmadiani, A., and Rahmani, B. (2013). Gemfibrozil pretreatment affecting antioxidant defense system and inflammatory, but not Nrf-2 signaling pathways resulted in female neuroprotection and male neurotoxicity in the rat models of global cerebral ischemia-reperfusion. Neurotox. Res. 23, 225-237.
68. Murakami, K., Kondo, T., Kawase, M., Li, Y., Sato, S., Chen, S.F., and Chan, P.H. (1998). Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J. Neurosci. 18, 205-213. (Pubitemid 28046782)
69. Nagra, R.M., Becher, B., Tourtellotte, W.W., Antel, J.P., Gold, D., Paladino, T., Smith, R.A., Nelson, J.R., and Reynolds, W.F. (1997). Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J. Neuroimmunol. 78, 97-107. (Pubitemid 27394430)
70. Newaz, M., Blanton, A., Fidelis, P., and Oyekan, A. (2005). NAD(P) H oxidase/nitric oxide interactions in peroxisome proliferator activated receptor (PPAR)α-mediated cardiovascular effects. Mutat. Res. 579, 163-171. (Pubitemid 41540140)
71. Oliver, C.N., Starke-Reed, P.E., Stadtman, E.R., Liu, G.J., Carney, J.M., and Floyd, R.A. (1990). Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/ reperfusion-induced injury to gerbil brain. Proc. Natl. Acad. Sci. USA 87, 5144-5147.
72. Ott, M., Gogvadze, V., Orrenius, S., and Zhivotovsky, B. (2007). Mitochondria, oxidative stress and cell death. Apoptosis 12, 913-922. (Pubitemid 46653300)
73. Paintlia, A.S., Paintlia, M.K., Singh, I., and Singh, A.K. (2006). IL-4-induced peroxisome proliferator-activated receptor gamma activation inhibits NF-κB trans activation in central nervous system (CNS) glial cells and protects oligodendrocyte progenitors under neuroinflammatory disease conditions: implication for CNS-demyelinating diseases. J. Immunol. 176, 4385-4398. (Pubitemid 44264419)
74. Patten, D.A., Germain, M., Kelly, M.A., and Slack, R.S. (2010). Reactive oxygen species: stuck in the middle of neurodegeneration. J. Alzheimers Dis. 20 (Suppl 2), S357-S367.
75. Pesant, M., Sueur, S., Dutartre, P., Tallandier, M., Grimaldi, P.A., Rochette, L., and Connat, J.L. (2006). Peroxisome proliferatoractivated receptor δ (PPARδ) activation protects H9c2 cardiomyoblasts from oxidative stress-induced apoptosis. Cardiovasc. Res. 69, 440-449. (Pubitemid 43098800)
76. Polak, P.E., Kalinin, S., Dello Russo, C., Gavrilyuk, V., Sharp, A., Peters, J.M., Richardson, J., Willson, T.M., Weinberg, G., and Feinstein, D.L. (2005). Protective effects of a peroxisome proliferator-activated receptor-β/δ agonist in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 168, 65-75. (Pubitemid 41396404)
77. Radermacher, K.A., Wingler, K., Langhauser, F., Altenhofer, S., Kleikers, P., Hermans, J.J., Hrabe de Angelis, M., Kleinschnitz, C., and Schmidt, H.H. (2013). Neuroprotection after stroke by targeting NOX4 as a source of oxidative stress. Antioxid. Redox Signal. 18, 1418-1427.
78. Reiter, R.J., Tan, D.X., Osuna, C., and Gitto, E. (2000). Actions of melatonin in the reduction of oxidative stress. A review. J. Biomed. Sci. 7, 444-458.
79. Ricote, M. and Glass, C.K. (2007). PPARs and molecular mechanisms of transrepression. Biochim. Biophys. Acta. 1771, 926-935. (Pubitemid 47198544)
80. Ristow, M. and Schmeisser, S. (2011). Extending life span by increasing oxidative stress. Free Radic. Biol. Med. 51, 327-336.
81. Sain, H., Sharma, B., Jaggi, A.S., and Singh, N. (2011). Pharmacological investigations on potential of peroxisome proliferator-activated receptor-γ agonists in hyperhomocysteinemia- induced vascular dementia in rats. Neuroscience 192, 322-333.
82. Sanguino, E., Ramon, M., Roglans, N., Alegret, M., Sanchez, R.M., Vazquez-Carrera, M., and Laguna, J.C. (2003). Gemfibrozil increases the specific binding of rat-cortex nuclear extracts to a PPRE probe. Life Sci. 73, 2927-2937. (Pubitemid 37176885)
83. Santhanam, A.V., d'Uscio, L.V., He, T., and Katusic, Z.S. (2012). PPARδ agonist GW501516 prevents uncoupling of endothelial nitric oxide synthase in cerebral microvessels of hph-1 mice. Brain Res. 1483, 89-95.
84. Santos, M.J., Quintanilla, R.A., Toro, A., Grandy, R., Dinamarca, M.C., Godoy, J.A., and Inestrosa, N.C. (2005). Peroxisomal proliferation protects from β-amyloid neurodegeneration. J. Biol. Chem. 280, 41057-41068. (Pubitemid 41780601)
85. Schnegg, C.I., Greene-Schloesser, D., Kooshki, M., Payne, V.S., Hsu, F.C., and Robbins, M.E. (2013). The PPARdelta agonist GW0742 inhibits neuroinflammation, but does not restore neurogenesis or prevent early delayed hippocampal-dependent cognitive impairment after whole-brain irradiation. Free Radic. Biol. Med. 61C, 1-9.
86. Schock, S.C., Xu, J., Duquette, P.M., Qin, Z., Lewandowski, A.J., Rai, P.S., Thompson, C.S., Seifert, E.L., Harper, M.E., and Chen, H.H. (2008). Rescue of neurons from ischemic injury by peroxisome proliferator-activated receptor-γ requires a novel essential cofactor LMO4. J. Neurosci. 28, 12433-12444.
87. Sergeeva, M.G., Aleshin, S.E., Grabeklis, S., and Reiser, G. (2010). PPAR activation has dichotomous control on the expression levels of cytosolic and secretory phospholipase A2 in astrocytes; inhibition in naive, untreated cells and enhancement in LPS-stimulated cells. J. Neurochem. 115, 399-410.
88. Shear, D.A., Dong, J., Gundy, C.D., Haik-Creguer, K.L., and Dunbar, G.L. (1998). Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry. 22, 1217-1240. (Pubitemid 28511596)
89. Sheng, H., Brady, T.C., Pearlstein, R.D., Crapo, J.D., and Warner, D.S. (1999). Extracellular superoxide dismutase deficiency worsens outcome from focal cerebral ischemia in the mouse. Neurosci. Lett. 267, 13-16. (Pubitemid 29251611)
90. Shi, Y., Hon, M., and Evans, R.M. (2002). The peroxisome proliferator-activated receptor δ, an integrator of transcriptional repression and nuclear receptor signaling. Proc. Natl. Acad. Sci. USA 99, 2613-2618. (Pubitemid 34240509)
91. Shimazu, T., Inoue, I., Araki, N., Asano, Y., Sawada, M., Furuya, D., Nagoya, H., and Greenberg, J.H. (2005). A peroxisome proliferator-activated receptor-γ agonist reduces infarct size in transient but not in permanent ischemia. Stroke 36, 353-359. (Pubitemid 40170822)
92. Singh, B., Sharma, B., Jaggi, A.S., and Singh, N. (2013). Attenuating effect of lisinopril and telmisartan in intracerebroventricular streptozotocin induced experimental dementia of Alzheimer's disease type: possible involvement of PPAR-γ agonistic property. J. Renin Angiotensin Aldosterone Syst. 14, 124-135.
93. Smith, C.D., Carney, J.M., Starke-Reed, P.E., Oliver, C.N., Stadtman, E.R., Floyd, R.A., and Markesbery, W.R. (1991). Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc. Natl. Acad. Sci. USA 88, 10540-10543. (Pubitemid 21915871)
94. Stefanova, N., Georgievska, B., Eriksson, H., Poewe, W., and Wenning, G.K. (2012). Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model. Neurotox. Res. 21, 393-404.
95. Sterin-Borda, L., Ganzinelli, S., Berra, A., and Borda, E. (2003). Novel insight into the mechanisms involved in the regulation of the m1 muscarinic receptor, iNOS and nNOS mRNA levels. Neuropharmacol. 45, 260-269. (Pubitemid 36782539)
96. Sun, X., Tang, Y., Tan, X., Li, Q., Zhong, W., Jia, W., McClain, C.J., and Zhou, Z. (2012). Activation of peroxisome proliferator-activated receptor-γ by rosiglitazone improves lipid homeostasis at the adipose tissue-liver axis in ethanol-fed mice. Am. J. Physiol. Gastrointest. Liver Physiol. 302, G548-557.
97. Takizawa, S., Matsushima, K., Shinohara, Y., Ogawa, S., Komatsu, N., Utsunomiya, H., and Watanabe, K. (1994). Immunohistochemical localization of glutathione peroxidase in infarcted human brain. J. Neurol. Sci. 122, 66-73. (Pubitemid 24073752)
98. Teissier, E., Nohara, A., Chinetti, G., Paumelle, R., Cariou, B., Fruchart, J.C., Brandes, R.P., Shah, A., and Staels, B. (2004). Peroxisome proliferator-activated receptor α induces NADPH oxidase activity in macrophages, leading to the generation of LDL with PPAR-α activation properties. Circ. Res. 95, 1174-1182. (Pubitemid 39648208)
99. Tureyen, K., Kapadia, R., Bowen, K.K., Satriotomo, I., Liang, J., Feinstein, D.L., and Vemuganti, R. (2007). Peroxisome proliferator-activated receptor-γ agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents. J. Neurochem. 101, 41-56. (Pubitemid 46426485)
100. Van Veldhoven, P.P. (2010). Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism. J. Lipid Res. 51, 2863-2895.
101. Walters, M.W. and Wallace, K.B. (2010). Urea cycle gene expression is suppressed by PFOA treatment in rats. Toxicol. Lett. 197, 46-50.
102. Wan, B. and Moreadith, R.W. (1995). Structural characterization and regulatory element analysis of the heart isoform of cytochrome c oxidase VIa. J. Biol. Chem. 270, 26433-26440.
103. Wang, Y.X., Zhang, C.L., Yu, R.T., Cho, H.K., Nelson, M.C., Bayuga-Ocampo, C.R., Ham, J., Kang, H., and Evans, R.M. (2004). Regulation of muscle fiber type and running endurance by PPARδ. PLoS Biol. 2, e294.
104. Wang, J.Y., Wen, L.L., Huang, Y.N., Chen, Y.T., and Ku, M.C. (2006a). Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation. Curr. Pharm. Des. 12, 3521-3533.
105. Wang, Z.J., Liang, C.L., Li, G.M., Yu, C.Y., and Yin, M. (2006b). Neuroprotective effects of arachidonic acid against oxidative stress on rat hippocampal slices. Chem. Biol. Interact. 163, 207-217. (Pubitemid 44572226)
106. Wang, Z.J., Liang, C.L., Li, G.M., Yu, C.Y., and Yin, M. (2007). Stearic acid protects primary cultured cortical neurons against oxidative stress. Acta. Pharmacol. Sin. 28, 315-326.
107. Wang, G., Liu, X., Guo, Q., and Namura, S. (2010). Chronic treatment with fibrates elevates superoxide dismutase in adult mouse brain microvessels. Brain Res. 1359, 247-255.
108. White, J.K., Auerbach, W., Duyao, M.P., Vonsattel, J.P., Gusella, J.F., Joyner, A.L., and MacDonald, M.E. (1997). Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nat. Genet. 17, 404-410. (Pubitemid 27518388)
109. Yap, Y.W., Whiteman, M., and Cheung, N.S. (2007). Chlorinative stress: an under appreciated mediator of neurodegeneration? Cell Signal. 19, 219-228. (Pubitemid 44969974)
110. Yi, J.H., Park, S.W., Brooks, N., Lang, B.T., and Vemuganti, R. (2008). PPARγ agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms. Brain Res. 1244, 164-172.
111. Yoo, S.E., Chen, L., Na, R., Liu, Y., Rios, C., Van Remmen, H., Richardson, A., and Ran, Q. (2012). Gpx4 ablation in adult mice results in a lethal phenotype accompanied by neuronal loss in brain. Free Radic. Biol. Med. 52, 1820-1827.
112. Yu, X., Shao, X.G., Sun, H., Li, Y.N., Yang, J., Deng, Y.C., and Huang, Y.G. (2008). Activation of cerebral peroxisome proliferator-activated receptors γ exerts neuroprotection by inhibiting oxidative stress following pilocarpine-induced status epilepticus. Brain Res. 1200, 146-158.
113. Zarzuelo, M.J., Jimenez, R., Galindo, P., Sánchez, M., Nieto, A., Romero, M., Quintela, A.M., López-Sepúlveda, R., Gómez- Guzmán, M., Bailón, E., et al. (2011). Antihypertensive effects of peroxisome proliferator-activated receptor-β activation in spontaneously hypertensive rats. Hypertension 58, 733-743.
114. Zemolin, A.P., Meinerz, D.F., de Paula, M.T., Mariano, D.O., Rocha, J.B., Pereira, A.B., Posser, T., and Franco, J.L. (2012). Evidences for a role of glutathione peroxidase 4 (GPx4) in methylmercury induced neurotoxicity in vivo. Toxicology 302, 60-67.
115. Zeng, Y., Xie, K., Dong, H., Zhang, H., Wang, F., Li, Y., and Xiong, L. (2012). Hyperbaric oxygen preconditioning protects cortical neurons against oxygen-glucose deprivation injury: role of peroxisome proliferator-activated receptor-γ. Brain Res. 1452, 140-150.
116. Zhao, X., Sun, G., Zhang, J., Strong, R., Song, W., Gonzales, N., Grotta, J.C., and Aronowski, J. (2007). Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor γ in microglia/ macrophages. Ann. Neurol. 61, 352-362. (Pubitemid 46676735)
117. Zhao, X., Strong, R., Zhang, J., Sun, G., Tsien, J.Z., Cui, Z., Grotta, J.C., and Aronowski, J. (2009). Neuronal PPARγ deficiency increases susceptibility to brain damage after cerebral ischemia. J. Neurosci. 29, 6186-6195.